New Technology– category –
-
Novel TROP2-Targeting ADC, hIMB1636-LDP-AE, Demonstrates Potent Antitumor Efficacy and Anti-Cancer Stem Cell Activity in Breast and Lung Cancers
Medium (@wuhanmabnus) China Overview A novel antibody-drug conjugate (ADC), hIMB1636-LDP-AE, engineered through genetic and molecular recombination technologies, has demonstrated potent antitumor efficacy in both in vitro and in vivo mod... -
Ultragenyx Announces Promising Phase 3 ASPIRE Results for Apazunersen (GTX-102), an ASO Therapeutic for Angelman Syndrome
Ultragenyx Pharmaceutical Inc. USA Overview Ultragenyx has reported promising results from its Phase 3 ASPIRE trial of Apazunersen (GTX-102), an ASO therapeutic for Angelman Syndrome. This drug, one of the first investigational agents ta... -
Gamgee Leverages ChatGPT and AlphaFold to Design Personalized mRNA Cancer Vaccine for Dogs, Accelerating Clinical Trials with AI
Gies Business (Facebook) USA Overview AI is proving to be a catalyst for accelerating all facets of clinical trials, exemplified by Gamgee's use of ChatGPT and AlphaFold to design a personalized mRNA cancer vaccine for dogs, now in clini... -
Isomorphic Labs and Recursion Pharmaceuticals Forge Major AI Drug Discovery Alliances with Pharma Giants
flcube.com International Overview Isomorphic Labs, an Alphabet subsidiary, has secured significant AI-driven drug discovery partnerships with Eli Lilly and Novartis to identify novel small molecule therapeutics for undisclosed targets. C... -
Insilico Medicine’s AI-Designed Drug Rentosertib Shows Early Signs of Biological Age Reversal, Enters Phase III for Idiopathic Pulmonary Fibrosis
Inc.com USA Overview Insilico Medicine's AI-generated small molecule, rentosertib, has demonstrated early signs of reducing six protein-based biological age markers by an average of 10.3% in a 12-week clinical trial. This breakthrough ma... -
Idemitsu Kosan Fortifies IP in Sulfide-Based Solid Electrolytes, Accelerating EV All-Solid-State Battery Commercialization
Pasona Career Japan Overview Idemitsu Kosan is strategically advancing the development and commercialization of sulfide-based solid electrolytes, a critical component for next-generation all-solid-state lithium-ion batteries. Leveraging ... -
Novel ETCRAM Device Integrates Synapse and Neuron Functions into Single Element, Demonstrating Over 1,000 TOPS/W for Matrix-Vector Multiplication in AI Hardware
XenoSpectrum Unknown Overview A new ETCRAM (Electrochemical Transistor based on Resistive Switching and Active Memory) device has demonstrated an operating principle that integrates synapse-like analog memory and neuron-like switching in... -
NEDO Project Drives Next-Gen Sodium-Ion Batteries for Mid-2030s Grid Storage, Prioritizing Longevity
NEDO Project, Tokyo University of Science Japan Overview Japan's New Energy and Industrial Technology Development Organization (NEDO) is backing a project to commercialize next-generation sodium-ion batteries (NIBs) for grid storage by t... -
Japan Leads All-Solid-State Battery Development: Solid Electrolyte Technology Unlocks Miniaturization, High Capacity, Fast Charging, and Extended Lifespan
Chemistry & Bio Japan Overview Japan is aggressively spearheading the development of all-solid-state batteries, leveraging solid electrolyte technology to deliver superior performance characteristics—including miniaturization, higher cap... -
Solid-State Battery Progress Accelerates: Xinyuren Trials Gen 2 Halide Electrolyte, Easpring Scales Sulfide Production, Dongfeng Plans 350 Wh/kg Hybrid EV Launch
Solid-State Battery Weekly China Overview The solid-state battery sector is witnessing rapid advancements, with Xinyuren successfully piloting its second-generation halide solid electrolyte and Easpring achieving large-scale production o...
